Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
AZD 6482
Cat. No.:
OB0225LY-0341
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
AZD 6482 ia a compound that selectively inhibits the PI3K/AKT signaling pathway.
Synonym:
KIN 193; AZD6482; 1173900-33-8; (R)-2-(1-(7-Methyl-2-morpholino-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino)benzoic acid; 2-[[(1R)-1-(7-Methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoic acid; 2-[[(1R)-1-[7-Methyl-2-(4-morpholinyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid
CAS No.:
1173900-33-8
Compound CID:
44137675
Formula:
C22H24N4O4
Formula Weight:
408.45
Specification
Relative Density:
1.36 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
AZD 6482 can be used for tumor proliferation studies, especially in studying the biology of cancers associated with the PI3K/AKT pathway.
Library Information
Targets:
DNA-PK; PI3K family
Receptors:
DNA-PK; PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ
Pathways:
Autophagy; DNA damage/DNA repair; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-5
Plate Location:
d5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 110.17 mM
Special Max Solubility:
1eq. HCl: 4.1 mg/mL
ALogP:
2.003
HBA_Count:
4
HBD_Count:
1
Rotatable Bond:
5
